Dermira Announces Positive Topline Phase 2b Clinical Trial Results for DRM01 in Patients with Facial Acne Vulgaris
10 mai 2016 06h00 HE
|
Dermira, Inc.
- Safety and Efficacy Data Confirm Results from Previous Phase 2a Trial - DRM01 Phase 3 Clinical Program Planning Underway - Management to Host Webcast and Conference Call Today at 5:30 a.m....
Dermira Announces Positive Phase 2b Results for DRM04 in Patients With Hyperhidrosis
05 févr. 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...